Skip to main content

Table 1 Study population and clinical characteristics

From: Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report

  Normal (n = 15) DM (n = 18) UAP (n = 18) DM + UAP (n = 21)
Age(y) 54.2 ± 11.4 56.2 ± 8.2 57.5 ± 10.5 55.3 ± 11.2
BMI(kg/m2) 23.7 ± 1.3 24.2 ± 5.3 25.1 ± 3.6 24.6 ± 4.1
Hypertension(n) 0 12* 14* 18*
Diabetes duration(y) --- 3.9 ± 1.0 --- 4.1 ± 0.8
TC(mmol/l) 3.1 ± 0.5 4.6 ± 1.4* 4.7 ± 2.0* 4.9 ± 1.8*
LDL-C(mmol/l) 1.6 ± 0.4 2.9 ± 0.7* 3.1 ± 0.8* 3.0 ± 1.5*
HDL-C (mmol/l) 1.2 ± 0.5 1.2 ± 0.7 1.1 ± 0.8 1.2 ± 0.6
TG (mmol/l) 1.3 ± 0.7 2.2 ± 1.8* 1.9 ± 1.5* 2.0 ± 1.6*
WBC(× 109) 5.9 ± 0.9 7.2 ± 0.8 7.5 ± 0.8 6.8 ± 1.0
Fasting glycaemia(mg/ml) 4.6 ± 0.7 8.5 ± 2.3#* 5.2 ± 1.2 8.1 ± 1.7#*
HbA1c(%) 4.4 ± 0.88 8.4 ± 2.5#* 5.1 ± 1.1 7.8 ± 1.8#*
Medications     
Statins 0 16 18 20
Aspirin 0 16 18 21
Fibrates 0 1 0 1
ACE inhibitor/ARB 0 13 14 17
  1. Results are expressed as mean ± SD. Normal: normal control subjects; DM: type 2 diabetic patients without CAD; UAP: non-diabetic patients with unstable angina pectoris; DM + UAP: type 2 diabetic patients with UAP; ACE: angiotensin-converting enzyme; ARB: angiotensin-receptor blocker. *p < 0.05 versus Normal; #p < 0.05 versus UAP.